Cite
HARVARD Citation
Cuylan, Z. et al. (2018). Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy. Journal of obstetrics and gynaecology research. 44 (7), pp. 1284-1293. [Online].